Skip to Content
You are currently on the new version of our website. Access the old version .

1 Result Found

  • Article
  • Open Access
3,065 Views
17 Pages

Drug Repositioning for HPV Clade-Specific Cervicouterine Cancer Using the OCTAD Pipeline

  • Joel Ruiz-Hernández,
  • Guillermo de Anda-Jáuregui and
  • Enrique Hernández-Lemus

20 November 2025

Cervical cancer remains a major global burden largely caused by persistent infection with high risk human papillomavirus (HPV). Biological differences between HPV clade A7 and HPV clade A9 may influence tumor programs and clinical outcomes. To propos...

(This article belongs to the Special Issue Future Challenges and Innovation in Gynecological Oncology)